Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China flag China · Delayed Price · Currency is CNY
65.26
+1.75 (2.76%)
Feb 3, 2026, 3:00 PM CST

SHA:688621 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
133.01177.41184.76156.47105.6672.46
Depreciation & Amortization
48.3348.3343.538.8327.479.61
Other Amortization
20.1620.1620.4814.015.915.23
Loss (Gain) From Sale of Assets
---0.04-0-
Asset Writedown & Restructuring Costs
0.310.310.710.210.520.08
Loss (Gain) From Sale of Investments
1.821.82-1.29-2.62-1.68-0.42
Provision & Write-off of Bad Debts
41.6841.6857.7718.6610.473.06
Other Operating Activities
94.2910.3112.6810.645.122.32
Change in Accounts Receivable
-326.37-326.37-250.51-151.92-143.04-35.13
Change in Inventory
-0.64-0.64-1.87-4.7-1.55-2.55
Change in Accounts Payable
70.2270.2248.7736.0581.748.65
Change in Other Net Operating Assets
12.9812.98----
Operating Cash Flow
71.5932.0292.86103.9688.2562.99
Operating Cash Flow Growth
-58.87%-65.52%-10.67%17.80%40.09%10.57%
Capital Expenditures
-7.51-30.48-72.96-103.87-84.96-27.03
Sale of Property, Plant & Equipment
0-000-
Cash Acquisitions
96-----4
Investment in Securities
-131.5-40-1789.75-192.51-5.09
Other Investing Activities
29.4827.861.292.621.680.42
Investing Cash Flow
-13.52-42.63-88.66-11.5-275.78-35.7
Short-Term Debt Issued
---216.17148.0137
Long-Term Debt Issued
-431.15393.49---
Total Debt Issued
492.74431.15393.49216.17148.0137
Short-Term Debt Repaid
----153.01-33.5-25.5
Long-Term Debt Repaid
--439.6-237.61-11.72-16.19-1.5
Total Debt Repaid
-406.61-439.6-237.61-164.72-49.69-27
Net Debt Issued (Repaid)
86.13-8.44155.8851.4598.3210
Issuance of Common Stock
----487.55-
Common Dividends Paid
-37.02-38.15-55.52-26.98-1.25-1.07
Other Financing Activities
-192.17-81.14-22.561.75-16.15-3.4
Financing Cash Flow
-143.06-127.7477.826.22568.485.52
Net Cash Flow
-84.99-138.3582118.68380.9532.82
Free Cash Flow
64.091.5419.90.093.2935.96
Free Cash Flow Growth
-49.43%-92.28%21552.67%-97.21%-90.84%14.89%
Free Cash Flow Margin
6.30%0.14%2.14%0.01%0.67%10.35%
Free Cash Flow Per Share
0.580.010.180.000.030.43
Cash Income Tax Paid
52.1765.4641.2432.812.0617.45
Levered Free Cash Flow
-15.53-54.66-53.26-49.86-26.783.66
Unlevered Free Cash Flow
-5.37-44.59-45.65-43.79-24.554.31
Change in Working Capital
-268.01-268.01-225.74-132.28-65.23-29.35
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.